FASN and fatty liver disease: Mice supplemented with palmitoleic acid exhibit higher fat deposition, hepatic steatosis, and increased hepatic expression of sterol regulatory element-binding protein 1c and fatty acid synthase, demonstrating the pro-lipogenic effect of this MUFA [33].